Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Antoine

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancerM Spielmann, T Dorval, F Turpin, et al.
Nature|May 2, 1996
Specific phosphorylation of SR proteins by mammalian DNA topoisomerase IF Rossi, E Labourier, T Forné, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Chemoimmunotherapy of metastatic malignant melanoma. The Salpétrière Hospital (SOMPS) experienceD Khayat, E Antoine, O Rixe, et al.
Annales De Medecine Interne|January 1, 1988
[Antithyrotropin receptor antibodies in a series of Basedow's disease]E Vidal, E Antoine, S Nadalon, et al.
Melanoma Research|December 1, 1995
Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patientsO Rixe, C Borel, D Paraiso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomasA Le Cesne, E Antoine, M Spielmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanomaD Khayat, C Borel, J M Tourani, et al.
The Journal of Cell Biology|January 10, 2001
Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motilityA Sanjay, A Houghton, L Neff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
Intravaginal Zinc Oxide Tetrapod Nanoparticles as Novel Immunoprotective Agents against Genital HerpesThessicar E Antoine, Satvik R Hadigal, Abraam M Yakoub, et al.
Nature Communications|April 28, 2015
Heparanase is a host enzyme required for herpes simplex virus-1 release from cellsSatvik R Hadigal, Alex M Agelidis, Ghadah A Karasneh, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancerM Spielmann, T Dorval, F Turpin, et al.
Nature|May 2, 1996
Specific phosphorylation of SR proteins by mammalian DNA topoisomerase IF Rossi, E Labourier, T Forné, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Chemoimmunotherapy of metastatic malignant melanoma. The Salpétrière Hospital (SOMPS) experienceD Khayat, E Antoine, O Rixe, et al.
Annales De Medecine Interne|January 1, 1988
[Antithyrotropin receptor antibodies in a series of Basedow's disease]E Vidal, E Antoine, S Nadalon, et al.
Melanoma Research|December 1, 1995
Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patientsO Rixe, C Borel, D Paraiso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomasA Le Cesne, E Antoine, M Spielmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanomaD Khayat, C Borel, J M Tourani, et al.
The Journal of Cell Biology|January 10, 2001
Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motilityA Sanjay, A Houghton, L Neff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
Intravaginal Zinc Oxide Tetrapod Nanoparticles as Novel Immunoprotective Agents against Genital HerpesThessicar E Antoine, Satvik R Hadigal, Abraam M Yakoub, et al.
Nature Communications|April 28, 2015
Heparanase is a host enzyme required for herpes simplex virus-1 release from cellsSatvik R Hadigal, Alex M Agelidis, Ghadah A Karasneh, et al.
Pageof 8